Novo Nordisk receives U.S. FDA clearance for the insulin injection device NovoPen Echo(R)

First insulin injection device to combine half-unit dosing with a memory function to help patients better manage their diabetes

PLAINSBORO, N.J., Aug. 21, 2013 -- (Healthcare Sales & Marketing Network) -- Novo Nordisk, a world leader in diabetes care, ... Biopharmaceuticals, Devices, Drug Delivery, FDANovo Nordisk, NovoPen Echo, NovoLog, insulin, diabetes

Source: HSMN NewsFeed - August 21, 2013 Category: Pharmaceuticals Source Type: news